Skip to main content

Enhertu Prices, Coupons and Patient Assistance Programs

Enhertu (fam-trastuzumab deruxtecan) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Metastatic, Non-Small Cell Lung Cancer, and others.

The cost for Enhertu intravenous powder for injection nxki 100 mg is around $2,855 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Enhertu prices

Intravenous Powder For Injection

Quantity Per unit Price
1 $2,854.57 $2,854.57

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Enhertu Coupons, Copay Cards and Rebates

Enhertu offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Enhertu Patient Savings Program

Eligible commercially insured patients may pay $0 per prescription with savings of up to $26,000 per year; offer can be used for the cost of the drug itself and may also cover up to $100 in infusion costs per administration in some states; for additional information contact the program at 833-364-3788.

Applies to:
Number of uses:
per prescription per year

Form more information phone: 833-364-3788 or Visit website

Patient Assistance & Copay Programs for Enhertu

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Enhertu (fam-trastuzumab deruxtecan-nxki) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Enhertu Patient Assistance Program

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. Not disclosed
  3. Not specified
  4. Must be residing in the US or US territory
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Please visit or call (833) 364-3788 for more information.
Applicable drugs:
  • Enhertu (fam-trastuzumab deruxtecan-nxki) Injection; IV

More information please phone: 833-364-3788 Visit Website